PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
1-Year Est. Return 13.3%
This Quarter Est. Return
1 Year Est. Return
+13.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.84B
AUM Growth
+$707M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1
+$140M
2
+$93.9M
3
+$84.7M
4
ARVN icon
Arvinas
ARVN
+$69.5M
5
TARS icon
Tarsus Pharmaceuticals
TARS
+$66.8M

Top Sells

1
+$90.7M
2
+$62M
3
+$41.8M
4
AUTL
Autolus Therapeutics
AUTL
+$39.5M
5
TGTX icon
TG Therapeutics
TGTX
+$37.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$314M 11.04%
4,177,830
+319,822
2
$266M 9.35%
3,818,095
+159,471
3
$217M 7.65%
552,120
+129,543
4
$149M 5.24%
2,389,902
+4,045
5
$146M 5.15%
3,124,749
+811,830
6
$140M 4.91%
+1,078,346
7
$116M 4.09%
1,787,176
+333,293
8
$111M 3.91%
1,982,006
+87,362
9
$108M 3.8%
2,614,935
+1,683,632
10
$107M 3.77%
2,484,874
+357,474
11
$104M 3.66%
2,863,406
+1,838,406
12
$98.5M 3.47%
2,330,508
13
$93.9M 3.31%
+2,914,975
14
$89.5M 3.15%
7,903,600
15
$88.1M 3.1%
5,031,420
+236,932
16
$84.7M 2.98%
+1,239,995
17
$84.1M 2.96%
2,121,163
-1,055,580
18
$80.8M 2.85%
3,246,759
-460,242
19
$76.8M 2.7%
507,952
+156,252
20
$66.9M 2.35%
3,135,387
+1,872,559
21
$44.6M 1.57%
+2,446,373
22
$41M 1.44%
6,425,803
-6,185,532
23
$36.3M 1.28%
+2,233,610
24
$29.6M 1.04%
2,818,908
+682,569
25
$25.8M 0.91%
+799,054
1
2